• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Participating Faculty

Publication
Article
Supplements and Featured PublicationsOncology and Managed Care: Evolving Trends for Better Patient Care
Volume 11
Issue 17 Suppl

The American Journal of Managed Care

This supplement to provides participants with currentinformation on oncology and how it affects managed care decision making, including coveragepolicy, reimbursement, and patient care. Jill Mullen, MPA, contributed to the writing ofDr McGivney's article. This supplement has been peer reviewed by an expert in the field.

Faculty

Guest Editor

William T. McGivney, PhD

Chief Executive Officer

National Comprehensive Cancer Network

Jenkintown, Pennsylvania

Guest Commentator

Lee N. Newcomer, MD

Oncology Services

UnitedHealth Group

Edina, Minnesota

Faculty Disclosure

In accordance with the ACCME, participants for this activity have completed conflict-of-intereststatements.

In compliance with the Health Insurance Portability and Accountability Act standards, no presentationsin this CME activity shall disclose the names or other identifiers of patients referencedwithout a signed waiver from the identified patient.

The American Journal of Managed Care

It is the policy of to have all faculty who participate inprograms sponsored by pharmaceutical organizations disclose any real or apparent conflictsof interest.

  • William T. McGivney, PhDServed on advisory panel for: Genentech

The following faculty member reports no relevant relationships with pharmaceutical companies:

  • Lee N. Newcomer, MD

Investigational and/or Off-label Use of Commercial Products and Devices

The University of Cincinnati College of Medicine requires all faculty to disclose any discussion ofinvestigational and/or off-label use of a pharmaceutical product or device within their presentation/report. Participants should note that the use of products outside US Food and DrugAdministration-approved labeling should be considered experimental and are advised to consultcurrent prescribing information for approved indications.

The faculty claim not to discuss any investigational and/or off-label use of a pharmaceutical productor device.

The American Journal of Managed Care,

Signed disclosures are on file at the offices of Jamesburg,New Jersey.

© 2024 MJH Life Sciences
AJMC®
All rights reserved.